Combinations Key For Amgen’s Lumakras, But PD-1/L1 Data Held Until August

Combo Importance Increases With Sales Growth Slowing

 
• By Mandy Jackson
Lungs icon, anatomy, health care concept
Amgen's first Lumakras combination therapy results in lung cancer will be presented at WCLC • Source: Shutterstock

More from Clinical Trials

More from R&D